Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules

被引:12
作者
Elkaeed, Eslam B. [1 ]
Abd El Salam, Hayam A. [2 ]
Sabt, Ahmed [3 ]
Al-Ansary, Ghada H. [4 ]
Eldehna, Wagdy M. [5 ]
机构
[1] AlMaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh 13713, Saudi Arabia
[2] Natl Res Ctr, Dept Green Chem, Cairo 12622, Egypt
[3] Natl Res Ctr, Chem Nat Cpds Dept, Cairo 12622, Egypt
[4] Ain Shams Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11566, Egypt
[5] Kafrelsheikh Univ, Fac Pharm, Dept Pharmaceut Chem, Kafrelsheikh 33516, Egypt
来源
MOLECULES | 2021年 / 26卷 / 24期
关键词
breast cancer therapy; organic synthesis; chemical scaffold; mechanistic insights; human malignancies; VITRO ANTIPROLIFERATIVE ACTIVITY; EMERGING TARGETED THERAPIES; TYROSINE KINASE INHIBITOR; BIOLOGICAL EVALUATION; QUINAZOLIN-4-ONE DERIVATIVES; SELECTIVE INHIBITORS; FERROCENYL COMPOUNDS; CYTOTOXIC ACTIVITY; DESIGN; POTENT;
D O I
10.3390/molecules26247611
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Among all cancer types, breast cancer (BC) still stands as one of the most serious diseases responsible for a large number of cancer-associated deaths among women worldwide, and diagnosed cases are increasing year by year worldwide. For a very long time, hormonal therapy, surgery, chemotherapy, and radiotherapy were used for breast cancer treatment. However, these treatment approaches are becoming progressively futile because of multidrug resistance and serious side effects. Consequently, there is a pressing demand to develop more efficient and safer agents that can fight breast cancer belligerence and inhibit cancer cell proliferation, invasion and metastasis. Currently, there is an avalanche of newly designed and synthesized molecular entities targeting multiple types of breast cancer. This review highlights several important synthesized compounds with promising anti-BC activity that are categorized according to their chemical structures.
引用
收藏
页数:31
相关论文
共 50 条
  • [31] Mechanistic insight and structure activity relationship of isatin-based derivatives in development of anti-breast cancer agents
    Singh, Atamjit
    Singh, Karanvir
    Sharma, Aman
    Sharma, Sambhav
    Batra, Kevin
    Joshi, Kaustubh
    Singh, Brahmjeet
    Kaur, Kirandeep
    Chadha, Renu
    Bedi, Preet Mohinder Singh
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (05) : 1165 - 1198
  • [32] Synthesis and Structure-Activity Relationship Study of Novel Pyrazolylthiazoles as Potential Anti-Breast Cancer Agents
    Abbas, Eman M. H.
    Dawood, Dina H.
    Farghaly, Thoraya A.
    El-hag, Fatma A.
    Ali, Mamdouh M.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (03) : 1974 - 1982
  • [33] Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents
    Zhang, Li
    Lei, Jine
    Shan, Yuanyuan
    Yang, Hao
    Song, Maxiaowei
    Ma, Ying
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (14) : 1999 - 2013
  • [34] Synthesis and in vitro Anti-breast Cancer Activity of Trametenolic acid B Derivatives
    Ding, Mingruo
    Zhang, Qiaoyin
    Hu, Fang
    Huang, Nianyu
    Wang, Junzhi
    ADVANCES IN CHEMICAL, MATERIAL AND METALLURGICAL ENGINEERING, PTS 1-5, 2013, 634-638 : 1135 - 1138
  • [35] Design and Synthesis of 4-substituted Quinazolines as Potent EGFR Inhibitors with Anti-breast Cancer Activity
    Ahmed, Marwa F.
    Magdy, Naja
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (06) : 832 - 838
  • [36] p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
    Chahat
    Bhatia, Rohit
    Kumar, Bhupinder
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 247
  • [37] Development of Furo[2,3-b]quinoline Derivatives with Anti-Breast Cancer Property by Targeting Topoisomerase II
    Wang, Ying
    Li, Na
    Jiang, Neng
    Chen, Li
    Sun, Jianbo
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (12) : 1482 - 1489
  • [38] Synthesis of a novel series of (Z)-3,5-disubstituted thiazolidine-2,4-diones as promising anti-breast cancer agents
    El-Kashef, Hussein
    Badr, Gamal
    El-Maali, Nagwa Abo
    Sayed, Douaa
    Melnyk, Patricia
    Lebegue, Nicolas
    Abd El-Khalek, Rofida
    BIOORGANIC CHEMISTRY, 2020, 96
  • [39] Development of a self-nanoemulsifying drug delivery system of diindolylmethane for enhanced bioaccessibility, bioavailability and anti-breast cancer efficacy
    Natesh, Jagadish
    Mukhlis, Yahya
    Ramasamy, Sumathy
    Mondal, Priya
    Kaur, Bhavjot
    Meeran, Syed Musthapa
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 93
  • [40] In vitro anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety
    Binjawhar, Dalal Nasser
    Al-Salmi, Fawziah A.
    Alghamdi, Maha Ali
    Abu Ali, Ola A.
    Fayad, Eman
    Rizzk, Youstina William
    Ali, Nourhan M.
    El-Deen, Ibrahim Mohey
    Eltamany, Elsayed H.
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (16) : 1665 - 1684